GlobeNewswire

Dahua Technology Launches ePoE IP System

Dela

Hangzhou, China, July 14, 2017 (GLOBE NEWSWIRE) --

Zhejiang Dahua Technology Co., Ltd., a leading solution provider in the global video surveillance industry, today announced the launch of a system of extended Power over Ethernet (ePoE) devices including cameras, network switches and network recorders. Dahua ePoE IP system supports up to 800 meters between the ePoE camera and the ePoE network switch or ePoE NVR with embedded switch. It overcomes the limitation of traditional Ethernet and POE (both restrict cable distances to 100 metres (328 feet) between network ports) and eliminated the need for Ethernet extension devices or additional network switches.

Product features

Dahua provides the complete solution for ePoE IP System including IP cameras, NVRs and Network switches. The system has the following features:

 

  1. Extended PoE transmission: 800m, 10Mbps, 13W or 300m, 100Mbps, 25.4W
  2. Automatic set up, plug & play
  3. Perfect for analog to IP migration: IP video, audio, control & power (4 in1) over coax cable; with LR1002 ePoE to BNC adaptor

http://www.freeuploadimages.org/images/pedrv05i015goepixnv.png

ePoE IP System

ePoE Series Network Cameras

The ePoE series IP cameras will be released in July 2017. They cover resolutions from 1080P to 4K, and have rich selections of camera form factors (box, bullet, dome, eyeball) and lens types (vari-focal, fixed lens), which can meet most surveillance requirements. Besides, as a sub-category of Eco-savvy 3.0 series, they inherit all the software features of Eco-savvy 3.0 series products, such as Smart Video Detection (Tripwire, Intrusion, Abandoned /Missing detection), Face Detection and Smart H.265+ encoding. It is a good choice for installers with long-distance transmission needs.

ePoE Series Network Recorders

The ePoE series network recorders will be released in September 2017. They have 8 green ePoE ports that support long-distance PoE transmission (300m@100Mbps/800m@10Mbps/EOC) when connecting to ePoE cameras. There are 3 models with 2/4/8 SATA ports respectively for different storage capacity. Advanced H.265 chipset is deployed to support 4K & H.265 decoding at a performance up to 16ch@1080P or 4ch@4K live view or playback. As a sub-category of Pro series NVR, it inherits all the software features of NVR5000-4KS2 series products, such as Smart Video Detection, Face Detection, Smart H.265+ decoding, ANPR, POS and custom split. It is compatible with standard Ethernet or PoE cameras and switches, perfect for migration of existing system.

ePoE Series Network Switch

The ePoE network switch PFL2106-4ET-96 has been released in Nov. 2016. It has 4 ePoE ports that support long-distance PoE transmission (300m@100Mbps/800m@10Mbps/EoC) when connected with ePoE cameras. It supports plug and play and no configuration required to realize long distance transmission. Additionally, ePoE series network switch adopts industrial grade design with wide operation temperature range (-30°C~+65°C) and high level lightning protection, which further save cost by eliminating the need for an equipment room. Besides, it is also compatible with the non-ePoE IP cameras (100m@100Mbps).

Power over Coaxial Extender LR1002

 

  • 1*10/100 Mbps Base-TX + 1*BNC
  • RG59 coaxial cable: 400m/100 Mbps, 1000m/10 Mbps
  • High level lightning protection
  • -30°C~+65°C

 

Application Scenarios

For surveillance of large space such as big warehouse, parks, garden and outdoor parking, camera locations are dispersed and far from the control center, usually longer than 100 meters. Conventional approach is to add repeater devices to extend the transmission distance. However, this would increase cost of equipment and installation. Power supply and junction box will be required to install the repeater. It also makes it harder to maintain and increases the risk of product failure. Alternately, fiber optic transceiver for long-distance transmission is also available. However, fiber optic cable has to be installed and it requires a power supply at the camera side to power the fiber optic transceiver as well as the camera. This is quite a big problem if you have a few installation points over a large space. Dahua ePoE IP system offer a very simple and effective solution. Dahua ePoE supports up to 800 meters via the traditional Cat5 ethernet cable. It greatly simplifies the network construction as only one cable is required to connect from the front-end to the back-end devices, which results in higher reliability and lower installation and maintenance costs of the whole system.

For migration of analog surveillance system to IP, reusing existing coaxial cable can largely reduce the installation cost. A proper solution needs to address 3 issues: adapt the IP video signal and RJ45 connection to coaxial cable, support the length of coaxial cable as it is, and transmit power over coaxial cable. Dahua ePoE IP system addresses all of them and makes it easy to reuse existing coaxial cable to run IP video. Power over Coaxial Extender LR1002 connects to Ethernet port of IP camera or network switch on the one end and connects to BNC connector of coaxial cable on the other end, Dahua ePoE IP system supports transmission up to 1,000 meters over RG59 coaxial cable at 10Mbit/s bandwidth, and delivers PoE power to the IP camera. This is a simple and effective solution that delivers seamless plug and play solution. It can significantly reduce the cost of analog to IP migration.

https://ibb.co/dDv1cv https://ibb.co/dDv1cv

Summary

The ePoE technology of Dahua adopts advanced 2D-PAM3 coding modulation from physical layer, and realizes full duplex transmission over 800 meters at the speed of 10Mbps, or 300 meters at the speed of 100Mbps via Cat5 or coaxial cable media. Dahua ePoE technology offer a new way to accomplish long distance transmission between IP camera and network switch. It allows more flexible surveillance system design, improves reliability and saves construction and wiring cost.

 

About Dahua Technology

Zhejiang Dahua Technology Co., Ltd. is a leading solution provider in the global video surveillance industry. In 2016, Dahua was ranked 4th in  " Security Top 50 "  by A&S international. Dahua is committed to providing the highest quality product with the latest technologies to enable our end users to perform their business successfully. The company has more than 6,000 R&D engineers and technical staff working on cutting-edge technologies in camera lens, image sensor, video encoding & transmission, embedded processor, graphic processing, video analytics, software reliability, network security and other technologies.

Visit  http://www.dahuasecurity.com t o learn more and follow us on  Facebook  and  LinkedIn .

 

 

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/db1f3a79-3208-4d92-a228-0c610b0b9b0c

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c29b5975-61e3-41c2-b38a-180cf63bb2bf

Vivid Gu
Dahua Technology
gu_jun1@dahuatech.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Dahua Technology via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum